Earnings Not Telling The Story For GKHT Medical Technology Co., Ltd. After Shares Rise 31 percent - Simply Wall St
| 002168 Stock | 2.62 0.04 1.50% |
About 62% of Shenzhen Hifuture's investor base is looking to short. The analysis of overall sentiment of trading Shenzhen Hifuture Electric stock suggests that many investors are alarmed at this time. The current market sentiment, together with Shenzhen Hifuture's historical and current headlines, can help investors time the market. In addition, many technical investors use Shenzhen Hifuture stock news signals to limit their universe of possible portfolio assets.
Shenzhen |
Earnings Not Telling The Story For GKHT Medical Technology Co., Ltd. After Shares Rise 31 Simply Wall St
Read at news.google.com
 |
Shenzhen Hifuture Fundamental Analysis
We analyze Shenzhen Hifuture's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shenzhen Hifuture using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shenzhen Hifuture based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Shenzhen Hifuture is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Shenzhen Hifuture Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shenzhen Hifuture stock to make a market-neutral strategy. Peer analysis of Shenzhen Hifuture could also be used in its relative valuation, which is a method of valuing Shenzhen Hifuture by comparing valuation metrics with similar companies.
Peers
Shenzhen Hifuture Related Equities
| 603615 | Chahua Modern | 0.71 |
| ||
| 002084 | Guangzhou Seagull | 1.85 |
| ||
| 300888 | Winner Medical | 3.72 |
| ||
| 002901 | Double Medical | 3.90 |
| ||
| 301370 | GKHT Medical | 4.91 |
| ||
| 002219 | Hengkang Medical | 5.43 |
| ||
| 600616 | Shanghai Jinfeng | 6.89 |
|
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Hifuture's price analysis, check to measure Shenzhen Hifuture's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Hifuture is operating at the current time. Most of Shenzhen Hifuture's value examination focuses on studying past and present price action to predict the probability of Shenzhen Hifuture's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Hifuture's price. Additionally, you may evaluate how the addition of Shenzhen Hifuture to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |